These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34694567)

  • 1. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.
    Winograd E; Germano I; Wen P; Olson JJ; Ormond DR
    J Neurooncol; 2022 Jun; 158(2):265-321. PubMed ID: 34694567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.
    Germano IM; Ziu M; Wen P; Ormond DR; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):225-253. PubMed ID: 35195819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    Farrell C; Shi W; Bodman A; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.
    Goodman AL; Velázquez Vega JE; Glenn C; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):179-224. PubMed ID: 35648306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.
    Redjal N; Nahed BV; Dietrich J; Kalkanis SN; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):165-213. PubMed ID: 33215343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    Olson JJ; Nayak L; Ormond DR; Wen PY; Kalkanis SN; Ryken TC;
    J Neurooncol; 2014 Jul; 118(3):557-99. PubMed ID: 24740195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults.
    Patrick HH; Sherman JH; Elder JB; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):167-177. PubMed ID: 35246769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
    Johnson DR; Glenn CA; Javan R; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):139-165. PubMed ID: 34694565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bevacizumab in the treatment of glioblastoma.
    Diaz RJ; Ali S; Qadir MG; De La Fuente MI; Ivan ME; Komotar RJ
    J Neurooncol; 2017 Jul; 133(3):455-467. PubMed ID: 28527008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    Olson JJ; Nayak L; Ormond DR; Wen PY; Kalkanis SN;
    J Neurooncol; 2014 Jul; 118(3):501-55. PubMed ID: 24740194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults.
    Ziu M; Goyal S; Olson JJ
    J Neurooncol; 2022 Jun; 158(2):255-264. PubMed ID: 34748120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congress of Neurological Surgeons systematic review and evidence-based guidelines for the treatment of adults with progressive glioblastoma update: introduction and methods.
    Olson JJ
    J Neurooncol; 2022 Jun; 158(2):133-137. PubMed ID: 34694566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Chemotherapy in the Management of Adults With Newly Diagnosed Metastatic Brain Tumors.
    Sherman JH; Lo SS; Harrod T; Hdeib A; Li Y; Ryken T; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E175-E177. PubMed ID: 30629221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lomustine and Bevacizumab in Progressive Glioblastoma.
    Wick W; Gorlia T; Bendszus M; Taphoorn M; Sahm F; Harting I; Brandes AA; Taal W; Domont J; Idbaih A; Campone M; Clement PM; Stupp R; Fabbro M; Le Rhun E; Dubois F; Weller M; von Deimling A; Golfinopoulos V; Bromberg JC; Platten M; Klein M; van den Bent MJ
    N Engl J Med; 2017 Nov; 377(20):1954-1963. PubMed ID: 29141164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
    Cuncannon M; Wong M; Jayamanne D; Guo L; Cove N; Wheeler H; Back M
    BMC Cancer; 2019 May; 19(1):445. PubMed ID: 31088401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy with single agent bevacizumab for recurrent glioblastoma.
    Chamberlain MC; Johnston SK
    J Neurooncol; 2010 Jan; 96(2):259-69. PubMed ID: 19593660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.